PHP51 Managements of Febrile Neutropenia Among Non-Hodgkin's Lymphoma Patients in Taiwan
نویسندگان
چکیده
منابع مشابه
External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma.
Febrile neutropenia (FN) is a common and serious complication of chemotherapy treatment. Clinical risk models may help to identify patients at high risk of FN but must undergo external validation before implementation in medical practice. Therefore, this study externally validated previously published clinical models of FN occurrence during chemotherapy in 240 patients with non-Hodgkin lymphoma...
متن کاملNon-Hodgkins Lymphoma presenting as Garcin’s Syndrome
An 80 year old man presented with a twelve month history of progressive multiple unilateral cranial nerve palsies. A gadolinium enhanced MRI scan of his head and neck was performed. This showed an extra-axial enhancing lesion, which enveloped the hemi-mandible at the level of the left inferior alveolar nerve, and a dumbbell shaped lesion within the cerebellopontine angle. An incisional biopsy w...
متن کاملEconomic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients: An Observational Study in Singapore.
in Solid Tumor and Lymphoma Patients – An Observational Study in Singapore Xiao-Jun Wang, B.Sc.(Pharm)1; Mabel Wong, MD2; Li-Yang Hsu, MD3; Alexandre Chan, PharmD, BCPS, BCOP 1,4 1 Department of Pharmacy, Faculty of Science, National University of Singapore, 2 Department of Medical Oncology, National Cancer Centre, Singapore 3 Department of Medicine, National University Health System Singapore,...
متن کاملPegfilgrastim Versus Filgrastim for Primary Prophylaxis of Febrile Neutropenia in Patients with non-Hodgkin’s Lymphoma: A Cost-Effectiveness Study
Aim: One method to deal with febrile neutropenia is the use of granulocyte colony stimulating factors (G-CSFs). Pegfilgrastim or Filgrastim injection can lead to a reduction in febrile neutropenia and severe neutropenia in patients receiving chemotherapy. This study aimed to compare the cost-effectiveness of using Pegfilgrastim, 3-day Filgrastim and 1-day Filgrastim medication strategies for th...
متن کاملCost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients.
BACKGROUND Febrile neutropenia is a serious toxicity of cancer chemotherapy that is usually treated in hospital. We assessed the cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in diffuse large B-cell lymphoma (DLBCL) patients undergoing chemotherapy. METHODS We used a Markov model that followed patients through induction chemotherapy to c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2012
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.102